Literature DB >> 3137040

Human serum antibody response in Campylobacter jejuni enteritis as measured by enzyme-linked immunosorbent assay.

P Herbrink1, H A van den Munckhof, M Bumkens, J Lindeman, W C van Dijk.   

Abstract

An ELISA for detection of IgG, IgA, and IgM antibody using an acid-glycine extract from Campylobacter jejuni as antigen was developed. To determine the value of this assay for the diagnosis of acute Campylobacter jejuni infections, the IgG, IgA, and IgM immune response against Campylobacter jejuni was investigated at various timepoints after infection in patients with culture-proven infection. A total of 112 sera from 46 patients and 78 sera from a control group were tested. All but one of the 46 patients with culture-proven Campylobacter jejuni enteritis developed IgG antibodies against Campylobacter jejuni. IgA and IgM ELISA both showed 97% specificity, and sensitivity of 63% and 30% respectively. IgG antibody titers generally remained at a constant level for more than 50 days, whereas IgA and IgM antibody titers declined more rapidly to normal values within 30 to 50 days after onset of clinical symptoms. Detection of Campylobacter jejuni specific IgA antibodies in a single serum sample provided the most useful assay for serological diagnosis of Campylobacter jejuni enteritis. The presence of Campylobacter jejuni specific IgM antibodies was the sole diagnostic criterion in three cases. Serological diagnosis of Campylobacter jejuni enteritis should therefore include both IgA and IgM antibody determination.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3137040     DOI: 10.1007/bf01962343

Source DB:  PubMed          Journal:  Eur J Clin Microbiol Infect Dis        ISSN: 0934-9723            Impact factor:   3.267


  13 in total

1.  Serological response to Campylobacter jejuni/coli infection.

Authors:  D M Jones; J Eldridge; B Dale
Journal:  J Clin Pathol       Date:  1980-08       Impact factor: 3.411

2.  Enzyme-linked immunosorbent assay for bovine immunoglobulin subclass-specific response to Brucella abortus lipopolysaccharides.

Authors:  V L Lamb; L M Jones; G G Schurig; D T Berman
Journal:  Infect Immun       Date:  1979-10       Impact factor: 3.441

3.  Human serum antibody response to Campylobacter jejuni infection as measured in an enzyme-linked immunosorbent assay.

Authors:  M J Blaser; D J Duncan
Journal:  Infect Immun       Date:  1984-05       Impact factor: 3.441

4.  Serum antibodies in Campylobacter enteritis.

Authors:  J Kaldor; H Pritchard; A Serpell; W Metcalf
Journal:  J Clin Microbiol       Date:  1983-07       Impact factor: 5.948

5.  Serotyping of Campylobacter jejuni and Campylobacter coli on the basis of thermostable antigens.

Authors:  J L Penner; J N Hennessy; R V Congi
Journal:  Eur J Clin Microbiol       Date:  1983-08       Impact factor: 3.267

6.  Serologic study of two clusters of infection due to Campylobacter jejuni.

Authors:  M J Blaser; D J Duncan; M T Osterholm; G R Istre; W L Wang
Journal:  J Infect Dis       Date:  1983-05       Impact factor: 5.226

7.  An acid extract as a common antigen in Campylobacter coli and Campylobacter jejuni strains.

Authors:  H Rautelin; T U Kosunen
Journal:  J Clin Microbiol       Date:  1983-04       Impact factor: 5.948

8.  Campylobacter colitis: histological immunohistochemical and ultrastructural findings.

Authors:  J P van Spreeuwel; G C Duursma; C J Meijer; R Bax; P C Rosekrans; J Lindeman
Journal:  Gut       Date:  1985-09       Impact factor: 23.059

9.  Comparison of agglutination, complement fixation and immunofluorescence tests in Campylobacter jejuni infections.

Authors:  K C Watson; E J Kerr
Journal:  J Hyg (Lond)       Date:  1982-04

10.  Serological studies in two outbreaks of Campylobacter jejuni infection.

Authors:  D M Jones; D A Robinson; J Eldridge
Journal:  J Hyg (Lond)       Date:  1981-10
View more
  8 in total

1.  Human antibody response to Campylobacter jejuni flagellin protein and a synthetic N-terminal flagellin peptide.

Authors:  I Nachamkin; X H Yang
Journal:  J Clin Microbiol       Date:  1989-10       Impact factor: 5.948

2.  Serodiagnosis of respiratory syncytial virus (RSV) infection in children as measured by detection of RSV-specific immunoglobulins G, M, and A with enzyme-linked immunosorbent assay.

Authors:  M J Meddens; P Herbrink; J Lindeman; W C van Dijk
Journal:  J Clin Microbiol       Date:  1990-01       Impact factor: 5.948

3.  Evaluation of procedures for outer membrane isolation from Campylobacter jejuni.

Authors:  Rhonda I Hobb; Joshua A Fields; Christopher M Burns; Stuart A Thompson
Journal:  Microbiology (Reading)       Date:  2009-03       Impact factor: 2.777

Review 4.  Campylobacter species and Guillain-Barré syndrome.

Authors:  I Nachamkin; B M Allos; T Ho
Journal:  Clin Microbiol Rev       Date:  1998-07       Impact factor: 26.132

5.  Longitudinal analysis of antibody responses to trachoma antigens before and after mass drug administration.

Authors:  Erica Brook Goodhew; Sheri Maria G Morgan; Andrew J Switzer; Beatriz Munoz; Laura Dize; Charlotte Gaydos; Harran Mkocha; Sheila K West; Ryan E Wiegand; Patrick J Lammie; Diana L Martin
Journal:  BMC Infect Dis       Date:  2014-04-22       Impact factor: 3.090

6.  Guillain-Barré Syndrome in Suriname; Clinical Presentation and Identification of Preceding Infections.

Authors:  Thomas Langerak; Irene van Rooij; Laura Doornekamp; Felicity Chandler; Mark Baptista; Harvey Yang; Marion P G Koopmans; Corine H GeurtsvanKessel; Bart C Jacobs; Barry Rockx; Kirsten Adriani; Eric C M van Gorp
Journal:  Front Neurol       Date:  2021-02-10       Impact factor: 4.003

7.  Structure of Campylobacter jejuni lipopolysaccharides determines antiganglioside specificity and clinical features of Guillain-Barré and Miller Fisher patients.

Authors:  C W Ang; J D Laman; H J Willison; E R Wagner; H P Endtz; M A De Klerk; A P Tio-Gillen; N Van den Braak; B C Jacobs; P A Van Doorn
Journal:  Infect Immun       Date:  2002-03       Impact factor: 3.441

Review 8.  Non-invasive diagnostic tests for Helicobacter pylori infection.

Authors:  Lawrence Mj Best; Yemisi Takwoingi; Sulman Siddique; Abiram Selladurai; Akash Gandhi; Benjamin Low; Mohammad Yaghoobi; Kurinchi Selvan Gurusamy
Journal:  Cochrane Database Syst Rev       Date:  2018-03-15
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.